Julie Schmidt
Contact information
Colleges
Julie Schmidt
Postdoctoral epidemiologist
Julie Schmidt is an epidemiologist whose primary research interest is in the role of modifiable risk factors in the aetiology of cancer. Her current work focuses on the relationship between metabolite profile and prostate cancer risk and on understanding how metabolite profile may be associated with dietary, hormonal, lifestyle and genetic factors. For these studies, large-scale prospective cohort data are utilised; this includes data from the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group (EHNBPCCG).
Julie joined the Cancer Epidemiology Unit in 2012 as a statistical epidemiologist. Later she started her doctoral studies in the same unit and obtained her DPhil on the ‘Epidemiology of Metabolite Profile and Prostate Cancer Risk’ in 2018. Before joining the unit, she studied Clinical Nutrition (BSc, VIA University College, Denmark, 2005-2009) and Health Science (MSc, Aarhus University, Denmark, 2010-2012).
Recent publications
-
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort
Journal article
Rothwell J. and SCHMIDT J., (2020), Clinical Gastroenterology and Hepatology
-
Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer.
Journal article
Darst BF. et al, (2020), J Natl Cancer Inst
-
Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Journal article
Schmidt JA. et al, (2020), Int J Cancer, 146, 720 - 730
-
Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort
Journal article
SCHMIDT J., (2019), Cancer Epidemiology, Biomarkers and Prevention
-
Prospective analysis of circulating metabolites and breast cancer in EPIC.
Journal article
His M. et al, (2019), BMC Med, 17